EUVIMEDEUVIMED entdecken
Crossref

Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori

Young-Min Kwon, Sung-Jae Kim, Jae Gon Lee, Sang Pyo Lee iD

Helicobacter · 2023

DOI: 10.1111/hel.12974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Helicobacter, 2023. Verfasst von Young-Min Kwon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Hallym University Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Macrolide antibiotics are widely used to treat various infections such as pneumonia and sinusitis, and previous exposure to macrolides is presumed to be a risk factor for standard triple therapy failure in Helicobacter pylori (H. pylori) eradication. We aimed to determine whether previous use of macrolide antibiotics could affect clarithromycin resistance of H. pylori . Materials and methods From the Korea National Health Insurance Service (NHIS2021‐1‐775) database, a total of 46,160 patients who were tested for clarithromycin resistance of H. pylori from 2016 to 2019 in Korea were identified. Their history of antibiotics in the past 10 years and history of respiratory comorbidity in the past 1 year were investigated.

Results

Clarithromycin resistance rate of H. pylori in Korea was 16.2%. A multivariate analysis revealed that female sex (OR: 1.472, p < .001), age > 50 years (OR: 1.340, p < .001), previous use of macrolide antibiotics (clarithromycin, OR: 2.902, p < .001; azithromycin, OR: 1.930, p < .001; erythromycin, OR: 2.060, p = .001; roxithromycin, OR: 2.022, p < .001), and history of respiratory comorbidity (sinusitis, OR: 1.271, p < .001; laryngopharyngitis, OR: 1.135, p = .032; bronchitis, OR: 1.245, p = .001; pneumonia, OR: 1.335, p = .026) were independent risk factors of clarithromycin resistance in H. pylori.

Conclusions

The use of macrolide antibiotics and a recent diagnosis of respiratory disease might increase clarithromycin resistance of H. pylori .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsHumansFemaleMiddle AgedClarithromycinAnti-Bacterial AgentsDrug Resistance, BacterialMacrolidesDrug Therapy, CombinationAmoxicillin

Stichwörter der Autor:innen

Helicobacter pyloriantibioticsdrug resistance

Substanzen

ClarithromycinAnti-Bacterial AgentsMacrolidesAmoxicillin

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.
  • Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.

ORCID-Profile: Sang Pyo Lee

Förderung

  • Hallym University Research Fund

Zitieren

APA

Kwon, Y. M., Kim, S. J., Lee, J. G., & Lee, S. P. (2023). Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori. Helicobacter. https://doi.org/10.1111/hel.12974

Vancouver

Kwon YM, Kim SJ, Lee JG, Lee SP. Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori. Helicobacter. 2023. doi:10.1111/hel.12974

BibTeX
@article{Kwon2023,
  author = {Kwon, Young-Min and Kim, Sung-Jae and Lee, Jae Gon and Lee, Sang Pyo},
  title = {Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori},
  journal = {Helicobacter},
  year = {2023},
  doi = {10.1111/hel.12974}
}
Kostenlos starten →